ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,712 | -64.9% | 1,903 | -55.9% | 0.00% | -100.0% |
| Q2 2023 | $36,219 | – | 4,317 | +47866.7% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 9 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $36,000 | -57.6% | 6,754 | -64.4% | 0.00% | 0.0% |
| Q1 2022 | $85,000 | +80.9% | 18,990 | +60.3% | 0.00% | 0.0% |
| Q4 2021 | $47,000 | -73.1% | 11,843 | -40.8% | 0.00% | -75.0% |
| Q3 2021 | $175,000 | +548.1% | 20,011 | +734.1% | 0.00% | +300.0% |
| Q2 2021 | $27,000 | +50.0% | 2,399 | +57.2% | 0.00% | – |
| Q1 2021 | $18,000 | +12.5% | 1,526 | -36.0% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 2,383 | +31.7% | 0.00% | – |
| Q3 2020 | $13,000 | +30.0% | 1,809 | -25.7% | 0.00% | – |
| Q2 2020 | $10,000 | -75.6% | 2,434 | -65.1% | 0.00% | -100.0% |
| Q4 2019 | $41,000 | +241.7% | 6,981 | +204.4% | 0.00% | +200.0% |
| Q3 2019 | $12,000 | +1100.0% | 2,293 | +1052.3% | 0.00% | – |
| Q2 2019 | $1,000 | -94.4% | 199 | -90.7% | 0.00% | -100.0% |
| Q4 2018 | $18,000 | +260.0% | 2,141 | +498.0% | 0.00% | – |
| Q3 2018 | $5,000 | -66.7% | 358 | -82.0% | 0.00% | -100.0% |
| Q2 2018 | $15,000 | +87.5% | 1,991 | +89.1% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | – | 1,053 | +4287.5% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 24 | -99.2% | 0.00% | -100.0% |
| Q3 2017 | $23,000 | – | 3,183 | +26425.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 12 | -96.7% | 0.00% | – |
| Q1 2017 | $2,000 | -90.0% | 360 | -90.4% | 0.00% | -100.0% |
| Q4 2016 | $20,000 | +300.0% | 3,760 | +549.4% | 0.00% | – |
| Q3 2016 | $5,000 | +66.7% | 579 | -9.0% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 636 | +307.7% | 0.00% | – |
| Q4 2015 | $1,000 | -87.5% | 156 | -88.0% | 0.00% | -100.0% |
| Q3 2015 | $8,000 | +300.0% | 1,305 | +493.2% | 0.00% | – |
| Q2 2015 | $2,000 | -84.6% | 220 | -82.3% | 0.00% | -100.0% |
| Q1 2015 | $13,000 | +550.0% | 1,244 | +200.5% | 0.00% | – |
| Q3 2014 | $2,000 | -60.0% | 414 | -46.9% | 0.00% | -100.0% |
| Q2 2014 | $5,000 | – | 779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |